Rwanda
With a population of 8.6 million, the central African nation of Rwanda has an estimated adult seroprevalence rate of 3 percent.
In 2003, ICAP's MTCT-Plus Initiative, in collaboration with the Rwandan Ministry of Health and other partners, began enrolling families in HIV care and treatment in the capital city Kigali. Today, ICAP supports the development of comprehensive, family-focused HIV/AIDS prevention, care, and treatment programs, including the provision of antiretroviral therapy (ART), at hospitals and health centers in Kigali and the Western Region. ICAP supports a range of capacity-building initiatives, including training and clinical mentoring programs for healthcare providers, laboratory and clinic renovations, and infrastructure improvements.
Other ICAP-supported activities include: ;
- Integrated tuberculosis/HIV care and treatment;
- Rapid HIV testing for adults and children;
- Diagnostic testing/analysis, including Dried Blood Spot DNA PCR testing for infants;
- Training programs for all cadres of healthcare providers of HIV/AIDS prevention, care, and treatment;
- Community outreach;
- HIV support groups, including medication and treatment adherence;
- Peer education programs;
- Social services/social support;
- Nutrition support;
- Referral services;
- Home-based/community-based visits;
- Development and implementation of patient-information systems;
- Pharmacy services;
- Laboratory support;
- Targeted evaluations.
